Emergency Preparedness Antibiotics
Original notice title
Sweden – Stock-control services – Beredskapsläkemedel - Antibiotika
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
40 / 100
Risk factors
Structured data indicates EU-funded, but XML notice states 'no-eu-funds'. This could affect compliance and reporting re...
Award criteria, eligibility criteria, and required documents are not provided in the notice, increasing uncertainty.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- SEK 20M estimated value
- Services contract
- 1 lot
- Duration until Dec 2028
- Stock-control services for antibiotics.
- Maintain a revolving reserve stock for emergency preparedness.
Show full summary
This tender by the Public Health Agency of Sweden (Folkhälsomyndigheten) seeks a supplier for stock-control services of antibiotics, requiring the supplier to maintain a revolving reserve stock for emergency preparedness. The contract is a non-framework service agreement with a planned duration from December 15, 2026, to December 31, 2028, with an option to extend up to two years. The estimated total value is SEK 20,000,000. The procedure is a negotiated procedure with call for competition, and submission is electronic via tendsign.com. The tender is restricted to pharmaceutical companies marketing antibiotics in Sweden.
Risks
Structured data indicates EU-funded, but XML notice states 'no-eu-funds'. This could affect compliance and reporting re...
Award criteria, eligibility criteria, and required documents are not provided in the notice, increasing uncertainty.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Supplier must be a pharmaceutical company marketing antibiotics in Sweden.
- Hold a revolving stock of specified volume reserved for the authority's emergency preparedness.
- Stock must be integrated into the normal product flow (revolving stock).
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
SOLNA, SWE
Website
Identifier
2021006545
Activity
Health
Lots (1)
LOT-0000
Emergency Preparedness Antibiotics
Procurement of various antibiotics, requiring the supplier to hold a revolving stock of specified volume reserved for the authority's emergency preparedness. The stock rotates as part of normal turnover.
EUR 1.8M
Estimated value
Location
Duration
Category
Award Criteria
Deadline
Award details
Denna upphandling omfattar olika sorters antibiotika och vänder sig till läkemedelsföretag som marknadsför antibiotika i Sverige. Leverantören ska hålla ett omsättningslager med i avtal specificerad volym reserverat för myndighetens beredskap. Omsättningslager avser en form av lagerhållning där varor kontinuerligt byts ut i takt med förbrukningen och ingår som en del av det ordinarie varuflödet.
Additional CPV codes
Value note
Show original TED data
Original lot title
Beredskapsläkemedel - Antibiotika
Original TED description
Denna upphandling omfattar olika sorters antibiotika och vänder sig till läkemedelsföretag som marknadsför antibiotika i Sverige. Leverantören ska hålla ett omsättningslager med i avtal specificerad volym reserverat för myndighetens beredskap. Omsättningslager avser en form av lagerhållning där varor kontinuerligt byts ut i takt med förbrukningen och ingår som en del av det ordinarie varuflödet.
Procurement Details
- Publication date
- 16 Jun 2026
- Languages
- Swedish
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 414672-2026
Documents (2)
Similar tenders
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Belgium – Pharmaceutical products – Antimycotica
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
40 / 100
Risk factors
Structured data indicates EU-funded, but XML notice states 'no-eu-funds'. This could affect compliance and reporting re...
Award criteria, eligibility criteria, and required documents are not provided in the notice, increasing uncertainty.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications